Article Information
History
- January 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Peter V. Coyle1,*,
- Hiam Chemaitelly2,3,
- Mohamed Ali Ben Hadj Kacem1,
- Naema Hassan Abdulla Al Molawi1,
- Reham Awni El Kahlout1,
- Imtiaz Gilliani1,
- Nourah Younes1,
- Zaina Al Kanaani1,
- Abdullatif Al Khal1,
- Einas Al Kuwari1,
- Adeel A. Butt1,9,
- Andrew Jeremijenko1,
- Anvar Hassan Kaleeckal1,
- Ali Nizar Latif1,
- Riyazuddin Mohammad Shaik1,
- Hanan F. Abdul Rahim4,
- Gheyath K. Nasrallah5,6,
- Hadi M. Yassine5,6,
- Mohamed G. Al Kuwari7,
- Hamad Eid Al Romaihi8,
- Mohamed H. Al-Thani8,
- Roberto Bertollini8 and
- Laith J. Abu-Raddad2,3,9
- 1Hamad Medical Corporation, Doha, Qatar
- 2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
- 4College of Health Sciences, QU Health, Qatar University, Doha, Qatar
- 5Biomedical Research Center, Qatar University, Doha, Qatar
- 6Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
- 7Primary Health Care Corporation, Doha, Qatar
- 8Ministry of Public Health, Doha, Qatar
- 9Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
- ↵*Correspondence: Dr. Peter V. Coyle, Virology Department, Hamad Medical Corporation, Doha, Qatar. Email: pcoyle{at}hamad.qa., Professor Laith J. Abu-Raddad, Infectious Disease Epidemiology Group, Weill Cornell Medicine - Qatar, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar. Telephone: +(974) 4492-8321. Fax: +(974) 4492-8333. E-mail: lja2002{at}qatar-med.cornell.edu.
Posted January 06, 2021.
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
